U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130396) titled 'Impact of Multivitamin (PhytoMulti(R)) and a Probiotic (UltraFlora(R) Balance Probiotic) on Gut Health of People Taking GLP-1 Medication' on Aug. 12.
Brief Summary: This is a single-arm, open-label clinical trial involving 100 participants who will undergo a total participation period of 12 weeks.
Study Start Date: Nov. 01, 2025
Study Type: INTERVENTIONAL
Condition:
GLP-1
Adults
Intervention:
DIETARY_SUPPLEMENT: Multivitamin and a Probiotic
The duration of trial intervention and participation for an individual participant is approximately 3 months (12 weeks). Screening, during which eligibility to participate in the trial is ...